Ardelyx | ARDX - Selling And Administration Expenses

Stock Price
5.78
Daily Change
0.12 2.12%
Monthly
-14.50%
Yearly
5.67%
Q1 Forecast
5.61

Ardelyx reported $83.61M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Amgen USD 1.94B 237M Dec/2025
Ardelyx USD 83.61M 378K Sep/2025
aTyr Pharma USD 4.8M 130K Sep/2025
Corcept Therapeutics USD 114.74M 7.77M Dec/2025
Curis USD 4.79M 100K Jun/2024
Sanofi EUR 2.75B 455M Dec/2025
TG Therapeutics USD 50.73M 12.64M Dec/2025
United Therapeutics USD 190.6M 38.6M Dec/2025
Xoma USD 11M 2.54M Jun/2024